Your browser doesn't support javascript.
loading
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma.
Zinzani, Pier Luigi; Salles, Gilles; Moskowitz, Alison J; Santoro, Armando; Mehta, Amitkumar; Barr, Paul M; Mehta-Shah, Neha; Collins, Graham P; Ansell, Stephen M; Brody, Joshua D; Domingo-Domenech, Eva; Johnson, Nathalie A; Cunningham, David; Ferrari, Silvia; Lisano, Julie; Krajewski, Jennifer; Wen, Rachael; Akyol, Alev; Crowe, Russell; Savage, Kerry J.
Afiliação
  • Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli," University of Bologna, Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.
  • Salles G; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Moskowitz AJ; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Santoro A; Humanitas University, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.
  • Mehta A; School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Barr PM; Department of Medicine, University of Rochester, Rochester, NY.
  • Mehta-Shah N; Division of Oncology, Washington University in St. Louis School of Medicine, St. Louis, MO.
  • Collins GP; Department of Hematology, Oxford University Hospitals NHS Trust, Churchill Hospital, Oxford, United Kingdom.
  • Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Brody JD; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Domingo-Domenech E; Clinical Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Johnson NA; Department of Medicine & Oncology, Jewish General Hospital, Montreal, QC, Canada.
  • Cunningham D; Royal Marsden Hospital, London, United Kingdom.
  • Ferrari S; Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Lisano J; Seagen Inc, Bothell, WA.
  • Krajewski J; Bristol Myers Squibb, Princeton, NJ.
  • Wen R; Bristol Myers Squibb, Princeton, NJ.
  • Akyol A; Bristol Myers Squibb, Princeton, NJ.
  • Crowe R; Bristol Myers Squibb, Princeton, NJ.
  • Savage KJ; BC Cancer, Vancouver, BC, Canada.
Blood Adv ; 8(10): 2400-2404, 2024 May 28.
Article em En | MEDLINE | ID: mdl-38531062
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Cutâneo de Células T / Linfoma de Células T Periférico / Nivolumabe / Brentuximab Vedotin Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Cutâneo de Células T / Linfoma de Células T Periférico / Nivolumabe / Brentuximab Vedotin Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2024 Tipo de documento: Article